Cost-Effectiveness of Prefusion F Protein-Based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States.

Seyed M MoghadasAffan ShoukatCarolyn E BawdenJoanne M LangleyBurton H SingerMeagan C FitzpatrickAlison P Galvani

Published in: medRxiv : the preprint server for health sciences (2023)

Vaccination of older adults would provide substantial direct health benefits by reducing outcomes associated with RSV-related illness in this population.

Keyphrases

respiratory syncytial virus
physical activity
public health
healthcare
mental health
binding protein
risk assessment